ОбзорГрафикНовостиTraderScreen

BNP Paribas Bonus Zert BAYN 30.12.../  DE000PC7C1B5  /

Frankfurt Zert./BNP
06.11.2024  21:40:13 Изменение+0.060 Бид21:52:31 Предложение06.11.2024 Базовый актив Цена исполнения Дата истечения Тип опциона
21.640EUR +0.28% -
Величина цены спроса: -		 -
Величина цены предложения: -		 BAYER AG NA O.N. 25.00 - 30.12.2024 Put
TeleTrader 6:33 Earnings preview: Asian companies in spotlight
TeleTrader 10.11 WEEKLY PREVIEW: Inflation, GDP reports take center stage
TeleTrader 16.08 Bayer jumps 10% after Roundup court win
GlobeNewswire 02.08 Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting A...
GlobeNewswire 11.07 AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational...
GlobeNewswire 25.06 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial
GlobeNewswire 30.05 Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
GlobeNewswire 30.05 BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire 29.05 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach
GlobeNewswire 28.05 Pairwise and Bayer Expand CRISPR Leafy Greens Market through Licensing Agreement
TeleTrader 14.05 Bayer's sales in Q1 at €13.7 billion, down 4.3%
GlobeNewswire 02.05 AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire 18.04 AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire 16.04 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire 11.04 Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire 09.04 AskBio Names Mansuo Shannon Chief Scientific Officer
GlobeNewswire 25.03 BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire 14.03 Bayer and Aignostics to collaborate on next generation precision oncology
GlobeNewswire 06.03 BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
TeleTrader 05.03 Bayer's Q4 sales at €11.9 billion
GlobeNewswire 04.03 BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
TeleTrader 04.03 Earnings preview: Bayer, Broadcom among those in calendar
GlobeNewswire 15.02 2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust
GlobeNewswire 13.02 Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
GlobeNewswire 13.02 First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure